• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Artificial Intelligence In Pharmaceutical Market

    ID: MRFR/HC/25130-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Artificial Intelligence In Pharmaceutical Market Size, Growth Research Report By Technology (Machine Learning, Natural Language Processing, Computer Vision, Other Technologies), By Application (Drug Discovery and Development, Clinical Trials, Manufacturing and Supply Chain, Marketing and Sales, Other Applications), By Deployment Model (Cloud-Based, On-Premise, Hybrid), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Healthcare Providers) - Competitor Industry Analysis and Trends Forecast Ti...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Artificial Intelligence In Pharmaceutical Market Infographic
    Summary Table of Contents Segmentation Download PDF

    Artificial Intelligence In Pharmaceutical Market Summary

    The Global Artificial Intelligence In Pharmaceutical Market is poised for substantial growth, expanding from 1.49 USD Billion in 2024 to 10.51 USD Billion by 2035.

    Key Market Trends & Highlights

    Artificial Intelligence In Pharmaceutical Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 21.37% from 2025 to 2032.
    • By 2035, the market valuation is projected to reach 12.5 USD Billion, indicating a robust upward trajectory.
    • in 2024, the market is valued at 1.49 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of artificial intelligence technologies due to increased efficiency in drug discovery is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.49 (USD Billion)
    2035 Market Size 10.51 (USD Billion)
    CAGR (2025-2035) 19.43%

    Major Players

    IBM, Microsoft, Google, Amazon, Oracle, Sanofi, Aventis, Bayer, AstraZeneca, NVIDIA, Roche, Pfizer, Novartis

    Artificial Intelligence In Pharmaceutical Market Drivers

    Rising Demand for Drug Discovery

    The Global Artificial Intelligence In Pharmaceutical Market Industry experiences a notable surge in demand for drug discovery solutions. AI technologies streamline the drug development process, significantly reducing time and costs associated with traditional methods. For instance, AI can analyze vast datasets to identify potential drug candidates, which accelerates the initial phases of research. As of 2024, the market is valued at approximately 1.49 USD Billion, reflecting the growing reliance on AI for efficient drug discovery. This trend is expected to continue, with projections indicating a market expansion to 12.5 USD Billion by 2035, driven by a compound annual growth rate of 21.37% from 2025 to 2035.

    Key Players and Competitive Insights

    Major players in Artificial Intelligence In the Pharmaceutical Market industry are continuously competing to enhance their product lines and services to stay ahead of the competition. Leading Artificial Intelligence In Pharmaceutical Market players are expanding their footprints by expanding their presence in new regions and collaborating with other companies. Artificial Intelligence In Pharmaceutical Market development is primarily focused on R&D activities and strategic partnerships. The Artificial Intelligence In Pharmaceutical Market Competitive Landscape is fragmented, with a number of small and medium-sized players competing for a share of the market. 

    Key players in artificial intelligence in the Pharmaceutical Market include IBM, Microsoft, Google, Amazon, and Oracle. These companies are investing heavily in R&D to develop new and innovative Artificial Intelligence In Pharmaceutical Market products and services. They are also forming partnerships with other companies to expand their reach and gain access to new markets.IBM is a leading provider of Artificial Intelligence In Pharmaceutical Market products and services. The company offers a wide range of solutions, including software, hardware, and services. IBM's Watson AI platform is a key component of its Artificial Intelligence In Pharmaceutical Market offerings.

    Watson is a cognitive computing platform that can be used to develop a variety of applications, including those for drug discovery, clinical trials, and patient management. Microsoft is another major player in artificial intelligence in the Pharmaceutical Market. 

    The company offers a range of products and services, including the Azure AI platform. Azure AI is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Microsoft is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry.Google is a leading provider of cloud-based services. The company offers a range of products and services that can be used to develop and deploy AI applications.

    Google Cloud AI is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Google is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry. Amazon is a leading provider of cloud-based services. 

    The company offers a range of products and services that can be used to develop and deploy AI applications. Amazon Web Services (AWS) is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Amazon is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry. Oracle is a leading provider of software and services. The company offers a range of products and services that can be used to develop and deploy AI applications.

    Oracle's AI platform is a key component of its Artificial Intelligence In Pharmaceutical Market offerings. Oracle's AI platform provides developers with a variety of tools and services for developing and deploying AI applications. Oracle is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry.

    Key Companies in the Artificial Intelligence In Pharmaceutical Market market include

    Industry Developments

    • Q2 2024: Sanofi, Formation Bio and OpenAI partner to build AI-powered software for drug development Sanofi announced a partnership with Formation Bio and OpenAI to develop custom AI software aimed at accelerating drug development, marking a significant collaboration between a major pharmaceutical company and leading AI technology firms.
    • Q2 2024: AstraZeneca Invests in AI Startup Absci to Accelerate Drug Discovery AstraZeneca made a strategic investment in Absci, an AI-driven drug discovery startup, to leverage Absci’s generative AI platform for designing new biologic drug candidates.
    • Q2 2024: Insilico Medicine Announces $80 Million Series D Funding to Advance AI-Driven Drug Discovery Insilico Medicine raised $80 million in Series D funding to further develop its end-to-end AI drug discovery platform and expand its pipeline of novel therapeutics.
    • Q3 2024: Pfizer and Tempus Announce Strategic Collaboration to Leverage AI for Oncology Drug Development Pfizer and Tempus entered a strategic collaboration to use Tempus’ AI and data analytics platform to accelerate the development of new oncology therapies.
    • Q2 2024: Exscientia and Merck KGaA Sign Multi-Year AI Drug Discovery Partnership Exscientia and Merck KGaA signed a multi-year partnership to use Exscientia’s AI platform for the discovery of novel small molecule drug candidates across multiple therapeutic areas.
    • Q1 2025: Recursion Pharmaceuticals Announces FDA Clearance of IND Application for AI-Designed Drug Recursion Pharmaceuticals received FDA clearance for its Investigational New Drug (IND) application for a novel therapy designed using its proprietary AI platform.
    • Q2 2025: Bayer Launches AI Innovation Lab for Pharmaceutical R&D in Berlin Bayer opened a new AI innovation lab in Berlin dedicated to accelerating pharmaceutical research and development through advanced machine learning and data analytics.
    • Q2 2024: BenchSci Raises $95 Million Series D to Expand AI-Driven Preclinical R&D Platform BenchSci secured $95 million in Series D funding to scale its AI-powered platform that accelerates preclinical research and drug discovery for pharmaceutical companies.
    • Q3 2024: GSK and PathAI Announce Partnership to Advance AI-Powered Biomarker Discovery GSK and PathAI formed a partnership to use PathAI’s machine learning technology for biomarker discovery and patient stratification in clinical trials.
    • Q1 2025: Novartis Appoints Chief AI Officer to Lead Digital Transformation in Drug Development Novartis appointed its first Chief AI Officer to oversee the integration of artificial intelligence across its drug development and clinical operations.
    • Q2 2025: Eli Lilly Acquires AI Drug Discovery Startup Cyclica for $250 Million Eli Lilly acquired Cyclica, a Toronto-based AI drug discovery company, to enhance its capabilities in computational drug design and accelerate its R&D pipeline.
    • Q2 2024: Roche and Genentech Launch AI-Driven Platform for Personalized Medicine Roche and Genentech launched a new AI-powered platform designed to support personalized medicine initiatives by integrating genomic, clinical, and real-world data.

    Future Outlook

    Artificial Intelligence In Pharmaceutical Market Future Outlook

    The Artificial Intelligence in Pharmaceutical Market is poised for growth at 19.43% CAGR from 2024 to 2032, driven by advancements in drug discovery, personalized medicine, and operational efficiencies.

    New opportunities lie in:

    • Develop AI-driven platforms for predictive analytics in clinical trials. Invest in AI solutions for drug repurposing and optimization. Create partnerships with tech firms to enhance AI capabilities in pharmaceutical research.

    By 2035, the market is expected to reach unprecedented levels, reflecting robust innovation and strategic partnerships.

    Market Segmentation

    Artificial Intelligence In Pharmaceutical Market End-User Outlook

    • Pharmaceutical Companies
    • Biotechnology Companies
    • Academic and Research Institutions
    • Healthcare Providers
    • Other End-Users

    Artificial Intelligence In Pharmaceutical Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Artificial Intelligence In Pharmaceutical Market Data Type Outlook

    • Structured Data
    • Unstructured Data
    • Both Structured and Unstructured Data

    Artificial Intelligence In Pharmaceutical Market Technology Outlook

    • Machine Learning
    • Natural Language Processing
    • Computer Vision
    • Other Technologies

    Artificial Intelligence In Pharmaceutical Market Application Outlook

    • Drug Discovery and Development
    • Clinical Trials
    • Manufacturing and Supply Chain
    • Marketing and Sales
    • Other Applications

    Artificial Intelligence In Pharmaceutical Market Deployment Model Outlook

    • Cloud-Based
    • On-Premise
    • Hybrid

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20241.49 (USD Billion)
    Market Size 203510.51 (USD Billion)
    Compound Annual Growth Rate (CAGR)19.43% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2018-2022
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledSanofi Aventis, Microsoft, Bayer, Google, IBM, AstraZeneca, NVIDIA, Amazon, Roche, Pfizer, Novartis
    Segments CoveredTechnology, Application, Deployment Model, End-User, Data Type, Regional
    Key Market OpportunitiesPrecision Medicine Drug Discovery Optimization Clinical Trial Management Personalized Treatment Plans Remote Patient Monitoring
    Key Market DynamicsGrowing demand for personalized medicine Increasing adoption of AI in drug discovery Advancements in machine learning and deep learning Government initiatives and funding Strategic partnerships and collaborations.
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 20251.78 (USD Billion)

    Leave a Comment

    FAQs

    What is the projected growth of the Artificial Intelligence In Pharmaceutical market?

    The Artificial Intelligence In Pharmaceutical market is the expected increase in total market value of 10.51 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Artificial Intelligence In Pharmaceutical market?

    Artificial Intelligence In Pharmaceutical market size was valued at approximately 1.49 billion USD in 2024. This figure will reach 10.51 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Artificial Intelligence In Pharmaceutical market?

    Artificial Intelligence In Pharmaceutical market is expected to grow at a CAGR of 19.43% between 2025 and 2035.

    How much will the Artificial Intelligence In Pharmaceutical market be worth by 2035?

    Artificial Intelligence In Pharmaceutical market is expected to be worth of 10.51 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Artificial Intelligence In Pharmaceutical market perform over the next 10 years?

    Over the next 10 years the Artificial Intelligence In Pharmaceutical market is expected to shift from usd billion 1.49 to 10.51 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What is the regional breakdown of the Artificial Intelligence In Pharmaceutical Market?

    North America held the largest share of AI in the pharmaceutical market and is expected to maintain its dominance throughout the forecast period. Europe is projected to witness a significant growth rate owing to the increasing adoption of AI in drug discovery and development.

    What are the key drivers of the Artificial Intelligence In Pharmaceutical Market?

    Major factors driving the growth of AI in the pharmaceutical market include the rising demand for personalized medicine, the need for faster and more efficient drug discovery and development processes, and the increasing adoption of AI in clinical trials.

    What are the key applications of Artificial Intelligence in the Pharmaceutical Industry?

    Key applications of AI in the pharmaceutical industry include drug discovery, clinical trials, personalized medicine, and manufacturing.

    Who are the major competitors in the Artificial Intelligence In Pharmaceutical Market?

    Major players operating in the Global AI in the Pharmaceutical Market include IBM, Microsoft, Google, Amazon, and Oracle.

    What is the outlook for the Artificial Intelligence In Pharmaceutical Market?

    The Global AI in Pharmaceutical Market is expected to witness substantial growth over the forecast period, driven by factors such as the increasing adoption of AI in drug discovery and development, the rising demand for personalized medicine, and the growing need for faster and more efficient clinical trials.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Stories
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization ✓ ✓ ✓
    Direct Access to Analyst ✓ ✓ ✓
    Deliverable Format ✓ ✓ ✓
    Platform Access ✗ ✗ ✓
    Discount on Next Purchase 10% 15% 15%
    Printable Versions ✗ ✗ ✓